BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $563,000 | -22.1% | 7,662 | 0.0% | 0.76% | -11.3% |
| Q2 2019 | $723,000 | +4.3% | 7,662 | -11.5% | 0.86% | -11.0% |
| Q1 2019 | $693,000 | -30.6% | 8,662 | -53.2% | 0.96% | -28.7% |
| Q4 2018 | $999,000 | -55.9% | 18,528 | -36.2% | 1.35% | -36.4% |
| Q3 2018 | $2,267,000 | +23.0% | 29,036 | 0.0% | 2.12% | +25.7% |
| Q2 2018 | $1,843,000 | -29.8% | 29,036 | +1.4% | 1.69% | -38.6% |
| Q1 2018 | $2,627,000 | +21.6% | 28,646 | 0.0% | 2.75% | +24.7% |
| Q4 2017 | $2,160,000 | +25.4% | 28,646 | +15.8% | 2.21% | +4.6% |
| Q3 2017 | $1,723,000 | +46.1% | 24,735 | +6.3% | 2.11% | +18.2% |
| Q2 2017 | $1,179,000 | – | 23,273 | – | 1.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |